The anti-inflammatory actions of ApoAI have been described in several conditions, such as sepsis (62), and decreases in plasma ApoAI have been associated with the severity of Alzheimer's disease (48). Here, APOA1 is linked to early-onset autosomal dominant Alzheimer disease.